Doctors are limited in how they can treat patients with myasthenia gravis, an autoimmune disease, to just treating its symptoms. The creation of a crystal model gives scientists new insight into a possible target for drug therapy development.
Doctors are limited in how they can treat patients with myasthenia gravis, an autoimmune disease, to just treating its symptoms. The creation of a crystal model gives scientists new insight into a possible target for drug therapy development.